Doctor profile · Federal record
Dr. PAMELA CRAVEN, M.D.
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Nuclear Cardiology Physician · OKLAHOMA CITY, OK
- NPI 1144214370
- Accepts Medicare
- MIPS 99.2 / 100 · 2023
- 36 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4050 W MEMORIAL RD FL 3
OKLAHOMA CITY, OK 731208382
(405) 608-3800
fax (405) 608-1524 - Mailing address
-
7800 NW 85TH TER
OKLAHOMA CITY, OK 731323385
Credentials & registration
- NPI registered
- September 2005 — 21 yrs on file
- Profile last updated
- June 6, 2022
- Year of graduation
- 1990 — 36 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State license (1)
- Oklahoma #17728
- Medicaid
- OK #100124510B
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1144214370. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,749
Distinct HCPCS
10
Medicare allowed
$257,062
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,733 | 1,148 | $93 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 497 | 468 | $66 | |
93880 |
Ultrasound of both sides of head and neck blood flow | 299 | 298 | $37 | |
93356 |
Heart muscle strain imaging | 229 | 226 | $11 | |
93010 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 209 | 195 | $8 | |
93297 |
Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 191 | 22 | $24 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 176 | 163 | $63 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 87 | 87 | $128 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 69 | 32 | $76 | |
99238 |
Hospital discharge day management, 30 minutes or less | 42 | 40 | $77 |
In context: peer comparison
Among 13 peers in this city , average services per provider: 125. This provider delivers 30× the peer median.Open Payments
Industry payments received
All-time total
$476
Transactions
20
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Philips North America LLC | 2 | $88.30 | |
| AstraZeneca Pharmaceuticals LP | 3 | $58.78 | |
| Novartis Pharmaceuticals Corporation | 3 | $56.52 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $55.76 | |
| Alnylam Pharmaceuticals Inc. | 2 | $54.11 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $47.89 | |
| Daiichi Sankyo Inc. | 2 | $41.61 | |
| Kestra Medical Technology Services, Inc. | 1 | $33.47 | |
| Amgen Inc. | 1 | $21.30 | |
| Novo Nordisk Inc | 1 | $18.31 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
8,538
Patients
2,465
Total drug cost
$1,997,700
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Rosuvastatin Calcium | Generic | 1,148 | 332 | $38,763 |
| Metoprolol Succinate | Generic | 980 | 293 | $24,046 |
| Eliquis (Apixaban) | Brand | 835 | 174 | $870,367 |
| Amlodipine Besylate | Generic | 821 | 245 | $8,229 |
| Atorvastatin Calcium | Generic | 788 | 246 | $14,873 |
| Losartan Potassium | Generic | 559 | 157 | $10,771 |
| Potassium Chloride | Generic | 445 | 158 | $16,770 |
| Entresto (Sacubitril/Valsartan) | Brand | 418 | 83 | $548,668 |
| Furosemide | Generic | 417 | 150 | $3,138 |
| Ezetimibe | Generic | 409 | 128 | $21,219 |